13
Jan
2025
RNA Editing Medicines: Ram Aiyar on The Long Run
Ram Aiyar is today’s guest on The Long Run. Ram is the CEO of Cambridge, Mass.-based Korro Bio. The company is developing medicines that edit RNA, instead of DNA, which more people have heard about. Previously, Ram co-founded Corvidia Therapeutics and served on the management team up through its $2.1 billion acquisition by Novo Nordisk. He’s had a long and... Read More
13
Jan
2025
Moving from Biotech to Nature
Everything started with my love for animals. I studied biology and journalism at the University of Warsaw — science because I loved nature, and journalism because I believed it would be my escape from the confines of post-communist Poland. I yearned to explore the world with friends, and did a variety of jobs – waiting tables, gorilla zookeeping, blackjack dealing... Read More